All products / DC12661
CT1812
Pack sizes and prices
| Pack size | Price |
|---|---|
| 10 mg | $400 USDRequest a quote / confirm availability → |
| 25 mg | $700 USDRequest a quote / confirm availability → |
| 50 mg | $1,200 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
Elayta (CT1812) is a novel allosteric antagonist of the sigma-2 receptor complex that prevents and displaces binding of Aβ oligomers to neurons. By stopping a key initiating event in Alzheimer's disease, this first-in–class drug candidate mitigates downstream synaptotoxicity and restores cognitive function in aged transgenic mouse models of Alzheimer's disease. CT1812 was well tolerated with single dose administration up to 1120 mg and with multiple dose administration up to 840 mg and 560 mg in healthy young and healthy elderly subjects, respectively. CT1812 is currently being studied in early phase 2 trials in patients with Alzheimer's disease.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC12661 |
|---|---|
| Product name | CT1812 |
| CAS | 1802632-22-9 |
| Molecular formula | C24H33NO4S |
| Molecular weight | 431.588125944138 |
| Purity | >98% |
| SMILES | CC(C)(C)Oc1cc(CCC(C)(C)N2Cc3ccc(S(C)(=O)=O)cc3C2)ccc1O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — CT1812 (DC12661)